JPRN-UMIN000051852招募中Unknown
Study of the efficacy of third-line eradication therapy with sitafloxacin in patients who failed Helicibacter pylori eradication. - Study of the efficacy of third-line eradication therapy with sitafloxacin in patients who failed Helicibacter pylori eradication.
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Pregnant or lactating patients (2) Patients with allergy to VPZ, MNZ, or STFX (3) Patients with severe liver, kidney, or heart dysfunction (4) Patients whose physician deems inappropriate (5) Patients who are allergic to penicillin and have used VPZ-MNZ-STFX triple therapy as primary or secondary eradication therapy.
研究者
相似试验
已完成
不适用
Myopia control with progressive spectacle lenses trialJuvenile onset myopiaEye - Diseases / disorders of the eyeACTRN12611000582954Carl Zeiss Vision165
已完成
不适用
A study to evaluate the efficacy of third regimen with vonoprazan for eradication of Helicobacter pylori resistant against first and second regimen.Helicobacter pylori infectionJPRN-UMIN000017061Shonan Kamakura General Hospital33
进行中（未招募）
1 期
A clinical research study involving an experimental drug named Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Alafenamide Single Tablet Regimen and Tenofovir Alafenamide single agent. This study evaluates if TAF single agent is effective against HIV-1 infected subjects when added to subject’s current antiretroviral regimen that is no longer effective to treat HIV-1 and if subjects can safely switch to E/C/F/TAF STR plus Atazanavir without increasing the amount of virus in their blood.HIV-1 InfectionMedDRA version: 19.0 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862EUCTR2013-002830-19-GBGilead Sciences, Inc.55
进行中（未招募）
1 期
A clinical research study involving an experimental drug named Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Alafenamide Single Tablet Regimen and Tenofovir Alafenamide Single Agent. This study evaluates if TAF SA is effective against HIV-1 infected subjects when added to subject’s current antiretroviral regimen that is no longer effective to treat HIV-1 and if subjects can safely switch to E/C/F/TAF STR plus atazanavir without increasing the amount of virus in their blood.HIV-1 InfectionMedDRA version: 17.0Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 100000004862EUCTR2013-002830-19-DEGilead Sciences, Inc.160
进行中（未招募）
不适用
Enterogermina (Bacillus Clausii ) in the management of Diarrhea in childreMedDRA version: 17.1Level: LLTClassification code 10000706Term: Acute diarrheaSystem Organ Class: 100000004856Acute diarrheaEUCTR2014-004636-19-Outside-EU/EEASanofi Aventis264